Spring Bank Pharmaceuticals, Inc. Business Finance Contracts & Agreements
23 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Loan Agreements (3)
- Purchase Agreements (1)
- Registration Rights Agreements (2)
- Stock Agreements (4)
- Trust Agreements (2)
- Underwriting Agreements (5)
- Warrant Agreements (4)
- Side Letter, dated June 30, 2021, to (a) the License and Collaboration Agreement, dated August 24, 2016, by and among BBB Holding Ltd (f/k/a F-star Gamma Limited, DBH ), F-star... (Filed With SEC on August 13, 2021)
- Venture Loan and Security Agreement, dated April 1, 2021, by and among F-star Therapeutics, Inc., as borrower, F-star Therapeutics Limited, as guarantor, and Horizon Technology... (Filed With SEC on May 17, 2021)
- Form of Warrant issued under the Venture Loan and Security Agreement, dated April 1, 2021 (Filed With SEC on May 17, 2021)
- Underwriting Agreement, dated May 6, 2021, between F-star Therapeutics, Inc. and SVB Leerink LLC (Filed With SEC on May 10, 2021)
- STING Antagonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare... (Filed With SEC on November 20, 2020)
- STING Agonist Contingent Value Rights Agreement, dated as of November 20, 2020, by and between Spring Bank Pharmaceuticals, Inc., F-star Therapeutics Limited, Computershare Inc.,... (Filed With SEC on November 20, 2020)
- Form of Restricted Stock Unit Agreement (Filed With SEC on May 7, 2020)
- Form of Amended and Restated Warrant (Filed With SEC on April 13, 2020)
- Loan and Security Agreement, dated September 3, 2019 (Filed With SEC on September 4, 2019)
- Underwriting Agreement, dated August 8, 2018, by and among the Company, Jefferies LLC and Piper Jaffray & Co (Filed With SEC on August 9, 2018)
- Spring Bank Pharmaceuticals, Inc. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on August 18, 2017)
- 2,884,615 Shares Spring Bank Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 23, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 21, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 21, 2016)
- Spring Bank Pharmaceuticals, Inc. Common Stock Purchase Warrant (Void after [ ], 2021) (Filed With SEC on May 13, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 27, 2016)
- Spring Bank Pharmaceuticals, Inc. Common Stock Purchase Warrant (Void after , 2021) (Filed With SEC on April 27, 2016)
- [] Shares Spring Bank Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 27, 2016)
- THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE LEGENDS AND THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THISWARRANT (Filed With SEC on March 9, 2016)
- [ ] Shares Spring Bank Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 9, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDED AND RESTATED LICENSE AGREEMENT BY AND... (Filed With SEC on January 15, 2016)
- SPRING BANK TECHNOLOGIES, INC. AND MICROLOGIXBIOTECH, INC. STOCK PURCHASE AGREEMENT DECEMBER 17, 2003 STOCK PURCHASE AGREEMENT (Filed With SEC on January 5, 2016)
- SPRING BANK PHARMACEUTICALS, INC. NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on January 5, 2016)
